fda glp-1 compounding enforcement september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes Congress Introduces SAFE Drugs Act

These medications can provide meaningful benefits for weight management and metabolic health, but questions about long-term use, maintenance, and stopping treatment are common

doi:10.1016/j.molmet.2019.09.010 Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V

These medications mainly work by reducing hunger or enhancing satiety, with the exception of orlistat, which blocks the body's fat absorption [46]

Both studies had the same lead author, Julia J

A new study from the UK Medical C*nnabis Registry brings hopeful insights: Patients reported measurable reductions in pain over 6 months Improvements in sleep, anxiety, and overall quality of life Findings highlight c*nnabis-based medicines as a promising option for CRPS management Read the full study here #GreenleafMedClinic #ChronicPainRelief #MedicalResearch #NeuropathicPain #CRPS To view or add a comment, sign in GLP-1s for everything? Once just for diabetes and weight loss, GLP-1 receptor agonists are now being studied for obstructive sleep apnea, substance use disorder, Alzheimers, and more